About this trial
To establish the reference range of the NTproBNP2 Test Kit (time-resolved immunofluorescence method) in apparently healthy Chinese population.
Eligibility criteria
Qualifiers
Voluntarily participate in this study and sign informed consent;
Body Mass Index (BMI) ≥18.5 and <28kg/ m2;
Age ≥18 years old;
Through the investigator's consultation with the subjects, evaluate the subjects who meet the requirements of the reference individual of this study (refer to the "reference individual questionnaire").
Disqualifiers
eGFR(estimated glomerular filtration rate) (formula: CKD-EPI, chronic kidney disease epidemiology collaboration) < 60 mL/min/1.732
Systolic blood pressure ≥130 mm Hg and/or diastolic blood pressure ≥80 mmHg
Glycated hemoglobin A1c (HbA1c) ≥ 6.0%; or fasting blood glucose ≥ 7.0 mmol/L
Total cholesterol ≥ 6.22 mmol/L and/or triglycerides ≥ 2.26 mmol/L
Trial design
Treatments tested in this trial
- Not listed